The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study
Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glyco...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Dove Medical Press
2017-12-01
|
| Ráidu: | International Journal of COPD |
| Fáttát: | |
| Liŋkkat: | https://www.dovepress.com/the-impact-of-indacaterolglycopyrronium-fixed-dose-combination-versus--peer-reviewed-article-COPD |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|